Reddy, M. V. Ramana; Reddy, D. Bhaskar; Reddy, P. V. Ramana, Phosphorus, Sulfur and Silicon and the Related Elements, 1990, vol. 53, # 1-4, p. 285 - 290
(E)-4-carboxystyrl-4-chlorobenzyl sulfone and pharmaceutical compositions thereof
申请人:——
公开号:US20030149109A1
公开(公告)日:2003-08-07
Pre-treatment with &agr;,&bgr; unsaturated aryl sulfones protects normal cells from the cytotoxic side effects of two classes of anticancer chemotherapeutics. Administration of a cytoprotective sulfone compound to a patient prior to anticancer chemotherapy with a mitotic phase cell cycle inhibitor or topoisomerase inhibitor reduces or eliminates the cytotoxic side effects of the anticancer agent on normal cells. The cytoprotective effect of the &agr;,&bgr; unsaturated aryl sulfone allows the clinician to safely increasing the dosage of the anticancer chemotherapeutic.
A new and novel five membered heterocycles thiadiazoles, oxadiazoles and triazoles were prepared from methyl 4-arylsulfonyl-3-arylbutyrate and methyl 4-arylmethanesulfonyl-3-arylbutyrate.
Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
申请人:——
公开号:US20040214903A1
公开(公告)日:2004-10-28
Pre-treatment with &agr;,&bgr; unsaturated aryl sulfones protects normal cells from the cytotoxic side effects of two classes of anticancer chemotherapeutics. Administration of a cytoprotective sulfone compound to a patient prior to anticancer chemotherapy with a mitotic phase cell cycle inhibitor or topoisomerase inhibitor reduces or eliminates the cytotoxic side effects of the anticancer agent on normal cells. The cytoprotective effect of the &agr;,&bgr; unsaturated aryl sulfone allows the clinician to safely increasing the dosage of the anticancer chemotherapeutic.
Formulations of radioprotective alpha, beta unsaturated aryl sulfones
申请人:Onconova Therapeutics, Inc.
公开号:EP2769719A1
公开(公告)日:2014-08-27
Solution and suspension formulations are provided for administration prior to or after exposure to ionizing radiation for reducing toxic effects of the radiation in a subject which comprises an effective amount of at least one radioprotective α, β unsaturated aryl sulfone wherein the composition has a pH within the range of about 8 to about 9.